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ABSTRACT
Leptin, adiponectin, and insulin are pivotal regulators for lipid and glucose metabolism. This study aimed to investigate 
the changes in these hormones in a rat model of metabolic syndrome (MetS) induced by high-carbohydrate high-fat (HCHF) 
diet. Twelve-week-old male Wistar rats were divided into two experimental groups. The normal group was given standard 
rat chow with tap water. The HCHF group was given HCHF diet with 25% fructose-supplemented drinking water to induce 
MetS. Body composition of the animals was measured using dual-energy X-ray absorptiometry. Blood was collected at 
week 0, 8, 12, and 16 for the measurement of blood glucose and hormone levels. Our findings demonstrated that HCHF 
diet significantly increased fat mass, percentage of fat, and decreased lean mass in the animals starting from week 8. 
The levels of blood glucose, leptin, and insulin were significantly higher but the level of adiponectin was significantly 
lower in the HCHF rats compared to the normal rats. In conclusion, hormones play a key underlying role in regulating 
lipid and glucose metabolism in MetS. 
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ABSTRAK
Hormon leptin, adiponektin, dan insulin merupakan pengawalatur untuk metabolisme lipid dan glukosa. Kajian ini 
bertujuan untuk mengkaji perubahan aras hormon dalam model tikus sindrom metabolik (MetS) yang diaruhkan oleh 
diet tinggi karbohidrat tinggi lemak (HCHF). Tikus jantan Wistar berumur 12 minggu dibahagikan kepada dua kumpulan. 
Kumpulan normal diberi makanan tikus piawai dan air paip. Kumpulan HCHF diberi diet HCHF dan air minuman yang 
ditambah dengan 25% fruktosa untuk mengaruh sindrom metabolik. Komposisi badan haiwan diukur menggunakan 
absorptiometer sinar-X. Darah haiwan dikumpul pada minggu 0, 8, 12, dan 16 untuk mengukur aras glukosa darah dan 
hormon. Keputusan kajian menunjukkan diet HCHF meningkatkan jisim lemak, peratusan lemak dan menurunkan jisim 
tanpa lemak secara signifikan dalam haiwan pada minggu ke-8. Aras glukosa darah, leptin dan insulin adalah lebih 
tinggi tetapi aras adiponektin adalah lebih rendah dalam tikus HCHF berbanding tikus normal. Kesimpulannya, hormon 
memainkan peranan dalam mengawalatur metabolisme lipid dan glukosa dalam MetS. 
Kata kunci: Adiponektin; glukosa; insulin; leptin; lipid
INTRODUCTION
Central obesity, hyperglycaemia, hypertension, 
hypertriglyceridemia, and low high-density lipoprotein 
(HDL) cholesterol are medical abnormalities that define 
metabolic syndrome (MetS) (Alberti et al. 2009). These 
abnormalities resulted from over-nutrition and physical 
inactivity, which together are stronger predictors of 
cardiovascular disease and type 2 diabetes mellitus 
than individual conditions. The underlying factors that 
unify this syndrome include insulin resistance, glucose 
intolerance, adiposity, adipose tissue dysfunction, 
and disordered lipid metabolism. Adipose tissue is an 
endocrine organ capable of synthesizing a wide variety 
of biologically active molecules, known as adipokines. 
The changes in adipokine secretion are often closely 
associated with MetS. 
 Leptin is an adipokine that has a major role in 
the regulation of energy homeostasis, appetite and 
metabolism in the state of energy excess or deficiency, 
and neuroendocrine function (Kelesidis et al. 2010). 
Adiponectin is another adipokine that has potent effects 
on glucose and lipid metabolism in skeletal muscle, 
cardiac muscle, and liver. Specifically, adiponectin 
regulates food intake, improves glucose uptake, fatty 
acid oxidation, as well as reduced glycogen synthesis, 
glucose production, and triglyceride content in these 
organs (Karbowska & Kochan 2006). Previous studies 
have consistently shown that leptin and adiponectin 
were respectively in direct and inverse correlation with 
body mass index (BMI), waist circumference, fat mass, 
insulin resistance, hyperinsulinemia, triglycerides, and 
low-density lipoprotein (LDL) cholesterol (Bazanelli et al. 
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2013; Izadi et al. 2013; Matsubara et al. 2002; Milewicz 
et al. 2010). 
 The co-occurrence of obesity and elevated circulating 
leptin levels are often caused by leptin resistance resulting 
in an imbalance between energy intake and expenditure 
(Morris & Rui 2009; Myers et al. 2010). Leptin resistance 
also causes the reduction of leptin-induced fatty acid 
oxidation and increases triglyceride content, resulting 
in the development of lipotoxicity (Harris 2014). On 
the contrary, adiponectin displays anti-atherogenic, anti-
inflammatory, and insulin-sensitizing effects. Adiponectin 
alleviates obesity-induced ectopic lipid accumulation and 
lipotoxicity by promoting fatty acid oxidation within the 
cells. Adiponectin also increases insulin sensitivity by 
reducing hepatic gluconeogenesis (Yamauchi et al. 2002). 
Therefore, leptin and adiponectin exert reciprocal effects 
in mediating the lipid and glucose metabolism. 
 Insulin is traditionally identified as a regulatory 
hormone for glucose homeostasis (Roberts et al. 2013). 
The stimulus for insulin secretion is the rise of blood 
glucose after a meal. Hence, glucose concentration is 
maintained within a very narrow range in the bloodstream. 
This is achieved by the regulation of glucose synthesis 
by the liver as well as glucose uptake by peripheral 
tissues such as skeletal muscle, liver, and adipose tissue. 
Additionally, insulin also exhibits control over lipid 
metabolism by attenuating lipolysis and concomitantly 
enhancing triglyceride storage in adipocytes (Chakrabarti 
et al. 2013). Insulin resistance is a hallmark feature of the 
MetS, characterized by the body not responding effectively 
to insulin. Hence, individuals with insulin resistance are 
also associated with the disturbance of lipid and glucose 
metabolism.
 Leptin, adiponectin, and insulin may be the hormones 
of interest mediating the abnormalities associated with 
MetS. The aim of this study was to evaluate the effects of 
high-carbohydrate high-fat (HCHF) diet on the level of these 
hormones that regulate lipid and glucose metabolism. 
MATERIALS AND METHODS
STUDY DESIGN
All animal experimentations were reviewed and approved 
by the Universiti Kebangsaan Malaysia Animal Ethics 
Committee (UKMAEC) (Code: PP/FAR/2015/IMA/20-
MAY/679-JUNE-2015-MAY-2017). Age-matched 
twelve-week-old male Wistar rats (n=14) weighed 
200 – 250 g were obtained from Laboratory Animal 
Resource Unit, Universiti Kebangsaan Malaysia (Kuala 
Lumpur, Malaysia). The rats were housed individually at 
Animal Laboratory, Department of Anatomy, Universiti 
Kebangsaan Malaysia (Kuala Lumpur, Malaysia) under 
standard ambient temperature (25 ± 2°C) with an alternate 
12-hour light-dark cycle. Upon acclimatization for one 
week, the animals were randomized into two experimental 
arms: the normal and HCHF groups. The normal rats were 
given standard rat chow (Gold coin, Port Klang, Malaysia) 
and tap water. The MetS-induced group was fed with 
a modified HCHF diet (consisting of 39.5% sweetened 
condensed milk, 20% ghee, 17.5% fructose, 15.5% 
powdered rat food, 2.5% Hubble Mendel and Wakeman 
salt mixture, and 5% water) plus 25% fructose (w/v) in 
drinking water (Wong et al. 2018b, 2017a). This MetS 
animal model has been successfully established using 
HCHF diet, whereby the components of MetS were partially 
developed at week 8 and fully developed at week 12 (Wong 
et al. 2017a). All food and drinks were provided ad libitum. 
The animals were euthanized after 16 weeks of feeding 
with assigned diet. 
EVALUATION OF BODY COMPOSITION
The rats were positioned in ventral recumbency on the scan 
table. Whole body scans were performed at week 0, 8, and 
16 to measure body composition (fat mass, lean mass, and 
percentage of fat) of the rats using the dual-energy X-ray 
absorptiometer (DXA) (Hologic QDR-1000 System, Hologic 
Inc., Waltham, USA) under general anaesthesia using the 
ketamine/xylazine/zoletil cocktail. All scans were analysed 
using the manufacturer’s recommended software calibrated 
for small animals. 
BIOCHEMICAL ASSAYS
Blood was collected via tail vein at week 0, 8, 12, and 16. 
Serum was extracted by centrifugation at 3000 rpm for 10 
min and stored at -70°C until analysis. The postprandial 
glucose level in serum was quantified using a colourimetric 
assay kit (Catalog number: DIGL-100, BioAssay Systems, 
USA). Serum levels of leptin (Catalog number: JP27295; 
IBL International GmbH, Hamburg, Germany), adiponectin 
(Catalog number: QY-E10886, Qayee Bio-Technology, 
Shanghai, China), and insulin (Catalog number: A05105, 
SPI-Bio, Bertin Pharma, Saclay, France) were evaluated 
using commercial enzyme-linked immunosorbent assay 
(ELISA) kits as per the manufacturer’s instructions. 
STATISTICAL ANALYSIS
The statistical analysis was conducted using Statistical 
Package for Social Sciences (SPSS) version 20 software 
(IBM, Armonk, NY, USA). The percentage change of body 
composition was calculated as ((reading at final – reading 
at baseline)/ reading at baseline × 100%). General linear 
(repeated) measure was used to analyse the significant 
difference for all the parameters between the study groups. 
All data were expressed as mean ± standard error of the 
mean (SEM). Value of p<0.05 was considered as statistical 
significance. 
RESULTS
Male rats fed with HCHF diet showed significant increases 
in fat mass (3.8-fold change) and percentage of fat (6.3-
fold change) but significant decrease in lean mass (0.2-
fold change) at week 8 as compared to the rats fed with 
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standard diet (p<0.05). Similar trend was observed in these 
parameters at week 16, whereby fat mass (4.7-fold change) 
and percentage of fat (5.3-fold change) were increased 
but lean mass was reduced (0.3-fold change) in the HCHF 
animals relative to the normal animals (Figure 1). The 
postprandial glucose concentration in serum of the HCHF 
rats was significantly higher than the normal rats at week 12 
(1.7-fold change) and week 16 (1.5-fold change) (p<0.05). 
For the hormone levels, as compared to the normal control, 
HCHF diet caused significant elevation of leptin (2.6- to 
5.1-fold change) and insulin (2.2- to 10.6-fold change) 
starting from week 8 until week 16 (p<0.05). Whereas 
HCHF diet caused significant reduction in adiponectin level 
in the serum of animals at week 12 (0.5-fold change) and 
week 16 (0.7-fold change) (p<0.05). The leptin/adiponectin 
ratio of the HCHF animals was also significantly higher 
compared to the normal controls from week 8 to week 16 
(p<0.05) (Figure 2). 
DISCUSSION
Other data obtained as part of this experiment was reported 
earlier (Wong et al. 2018a, 2017a, 2017b). Those papers 
reported on the successful induction of MetS in animals 
using HCHF diet. Elevations of systolic blood pressure, 
triglyceride, total cholesterol, and LDL cholesterol were 
observed after 8 weeks of HCHF diet. Other components of 
MetS including the increase in abdominal circumference, 
diastolic blood pressure, fasting blood glucose, glucose 
intolerance, and the decrease in HDL cholesterol were 
detected after 12 weeks of HCHF diet (Wong et al. 
2018a, 2017a, 2017b). In this paper, we reported data 
on the effects of HCHF diet on hormonal changes which 
potentially modulated the lipid and glucose metabolism 
in animals with MetS. Results from this study indicated 
that HCHF diet significantly raised leptin and insulin 
levels, while reduced adiponectin level in male rats. The 
animals fed with HCHF diet also had higher postprandial 
glucose level and fat content with concomitantly lower 
lean mass as compared to the normal controls. 
 Leptin is the protein encoded by the obese gene. 
The level of leptin is directly proportional to body fat 
mass. Leptin receptor is abundantly expressed in many 
organs including hypothalamus, heart, liver, kidney, 
pancreas, muscle, and adipose tissue, indicating the 
wide range of targets and widespread effects for leptin 
(Amitani et al. 2013). Under normal physiological 
conditions, leptin binds to its receptor and decreases 
food intake, increases energy expenditure, facilitates 
glucose utilization, and improves insulin sensitivity 
in the maintenance of metabolic balance (Srikanthan 
et al. 2016). In contrast, chronic carbohydrate and fat 
consumption evokes a decrease in leptin sensitivity, 
known as leptin resistance. Numerous in vivo studies 
showed that animals maintained on high-fat diet exhibited 
marked hyperleptinemia (Handjieva-Darlenska & 
Boyadjieva 2009; Jiang et al. 2009; Lin et al. 2000). The 
consumption of HCHF diet in this study resulted in the 
increase in fat mass and subsequently a positive trigger for 
more leptin production by fat tissues. Mechanistically, the 
impairment in leptin transportation, attenuation in leptin 
signalling, endoplasmic reticulum (ER) stress, deficiency 
in autophagy, and chronic inflammatory state are the 
common causes of obesity-associated leptin resistance 
FIGURE 1. Percentage change of body composition (fat mass, lean mass, and percentage of fat) in the normal 
and HCHF rats at week 8 and 16 compared to baseline (week 0). The data are expressed as mean ± SEM. 
Letter ‘a’ represents significant difference (p<0.05) compared to the normal group
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(Li & Li 2016). Therefore, leptin resistance disturbs the 
normal leptin signalling and function by causing: the 
imbalance of energy homeostasis and body weight by 
the central nervous system, the inhibition of fatty acid 
oxidation and glucose uptake in the skeletal muscle, 
the induction of insulin and glucagon secretion by the 
pancreas, the elevation of ectopic lipid accumulation in 
the liver, and the increase of free fatty acids (FFA) release 
from adipose tissue via lipolysis (Harris 2014; Jung & 
Choi 2014; Li & Li 2016). 
 Adiponectin is an adipocytokine chiefly produced 
by fat cells. The circulating adiponectin level is 
paradoxically related to fat mass. Similar to leptin, 
adiponectin receptors such as AdipoR1 and AdipoR2 
are predominantly found in skeletal muscle and liver to 
regulate lipid and glucose metabolism. Previous studies 
reported that low levels of adiponectin in serum can be 
a strong predictor for MetS (Kim et al. 2013), insulin 
resistance (Awazawa et al. 2011) and type 2 diabetes 
(Yamamoto et al. 2014). Previous studies reported the 
reductions in adiponectin gene and protein expression 
under high-fat dietary condition in animals (Barnea et 
al. 2006; Landrier et al. 2017). Congruent with these 
past findings, our results demonstrated that the animals 
with MetS induced by HCHF diet had a lower level of 
adiponectin compared to the normal control animals. 
Adiponectin helps in maintaining systemic energy 
balance by enhancing fatty acid oxidation, triglyceride 
catabolism, and fatty acid uptake (Lee & Shao 2012). 
The underlying mechanisms of action of adiponectin 
include the activation of peroxisome proliferator activated 
receptor (PPAR) and adenosine monophosphate-activated 
protein kinase (AMPK) (Ghadge et al. 2018). A study 
by Nawrocki et al. (2006) reported that mice lacking 
adiponectin showed decreased hepatic insulin sensitivity 
and reduced responsiveness to PPARγ agonists. Another 
study indicated that the transgenic mice with elevated 
circulating adiponectin displayed improved insulin 
sensitivity and increased lipid clearance in the liver 
through increased AMPK activity (Combs et al. 2004). 
Hence, the reduction of adiponectin in the animals fed 
with HCHF diet might be one of the contributing factors 
FIGURE 2. Levels of glucose, leptin, adiponectin, and insulin in the normal and HCHF rats at week 0, 8, 12, and 
16. The data are expressed as mean ± SEM. Letter ‘a’ represents significant difference (p<0.05) compared to the 
normal group and symbol ‘*’ represents significant difference (p<0.05) compared to week 0
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for the imbalance in blood glucose and energy profile 
leading to MetS. 
 Insulin is a peptide hormone secreted by β-cells of the 
pancreatic islet to regulate metabolism of carbohydrates, 
fats, and proteins. Under normal condition, insulin is 
secreted to enhance glycolysis process and lower glucose 
level by increasing the transportation of glucose from the 
bloodstream to body cells when glucose concentration is 
high, such as after eating (Qaid & Abdelrahman 2016). 
In the state of over-nutrition and excessive intake of fat, 
accumulation of triglyceride in the organs causes insulin 
resistance thus glucose builds up in the bloodstream, 
leading to diabetes (Wong et al. 2016). A human study 
conducted by von Frankenberg et al. (2017) indicated 
that overweight adults fed on a diet high in fat especially 
saturated fat had decreased insulin sensitivity. Our 
results demonstrated comparable outcomes that HCHF 
diet increased insulin and postprandial glucose levels, 
suggesting the occurrence of insulin resistance during 
MetS. Apart from regulating glucose metabolism, insulin 
signalling is uniquely involved in lipid metabolism, 
which functions to maintain the capacity of adipose 
tissue in triglyceride synthesis and storage under healthy 
conditions. Paradoxically, chronic hyperinsulinemia 
increases cytokines within adipose tissue leading to the 
dysfunction in the control of lipogenesis (Czech et al. 
2013). Taken together, insulin resistance during MetS 
is closely associated with the increase of triglyceride 
accumulation in liver and the decrease triglyceride storage 
in the adipose tissue. 
 Overall, findings from the present study validated the 
role of leptin, adiponectin, and insulin as the hormones 
that affect fuel metabolism, particularly in the regulation 
of lipid and glucose metabolism during MetS (Figure 
3). However, some limitations of this study need to 
be addressed. Firstly, food intake was not recorded. 
Secondly, the hormones and adipokines measured were 
limited. Thirdly, the evaluation of lipoprotein lipase (an 
enzyme responsible for hydrolysing triglycerides and 
promoting cellular uptake of fatty acids) was not carried 
out. 
CONCLUSION
Leptin, adiponectin, and insulin may act as a central 
rheostat that controls the energy balance tightly during 
MetS. These hormones respond to the nutrient flux and 
equilibrate the energy demands in maintaining systemic 
metabolic homeostasis. The uncoupling of hormonal 
signalling potentially leads to the development of various 
metabolic abnormalities associated with MetS. In this 
context, the evaluation of leptin, adiponectin, and insulin 
levels may be a valuable panel of biomarkers for early 
detection of MetS. 
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